ARIAD PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
15 Oct 2021	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other · Theseus Pharmaceuticals, Inc.
19 Jul 2016	Form 3: Kogan Elona Esq., Sr. V. P. - General Counsel No securities owned
08 Jun 2016	Form 3: Gansler Jayne M., Senior V.P. Human Resources No securities owned
01 Jun 2016	Form 3: Herron Jennifer Lyn, Exec V.P. Chief Comm'l Officer No securities owned
06 May 2016	Form 3: Haimovitz Jules, Director No securities owned
06 May 2016	Form 3: Bickerstaff George, Director No securities owned
21 Mar 2016	Form 3: Soni Manmeet Singh, EVP, CFO & Treasurer No securities owned
06 Jan 2016	Form 3: Panayiotopoulos Paris, Director No securities owned
29 Apr 2015	Form 3: Protopapas Anna, Director No securities owned
30 Jan 2015	Form 3: DesRosier Thomas, EVP, General Counsel No securities owned
08 Apr 2014	Form 3: Cole Hugh M, SVP, Chief Business Officer No securities owned
24 Feb 2014	Form 3: Denner Alexander J, Director Holds 4,816,801 shares of Common Stock
17 Jul 2013	Form 3: Schlesinger Sarah J., Director No securities owned
23 Feb 2012	Form 3: Cantor Maria E, SVP, Corporate Affairs Holds 7,277 shares of Common Stock
13 Sep 2011	Form 3: Duvall Martin J, SVP, Commercial Operations No securities owned
02 May 2011	Form 3: Riedel Norbert G, Director Holds 37,000 shares of Common Stock
24 Jun 2010	Form 3: Haluska Frank, VP, Clinical R&D, CMO Holds 14,931 shares of Common Stock
21 Apr 2010	Form 3: Whelan, Jr. Robert M., Director No securities owned
10 Apr 2009	Form 3: Ros Matthew E, Senior VP, Commercial Ops
10 Apr 2009	Form 3: Bollag Daniel M, Sr. VP, Reg. Affairs & Quality

Comments